Pali Research Initiates Coverage on Vitamin Shoppe (VSI) with a Buy; Solid EPS Growth Opportunity

November 23, 2009 7:27 AM EST Send to a Friend
Pali Research initiates coverage on Vitamin Shoppe, Inc (NYSE: VSI) with a Buy. Price target $22.

Pali analyst says, "VSI ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login